AMARIN ($AMRN) posted quarterly earnings results on Wednesday, October 29th. The company reported earnings of $0.01 per share, beating estimates of -$0.58 by $0.59. The company also reported revenue of $49,670,000, beating estimates of $43,961,316 by $5,708,684.
You can see Quiver Quantitative's $AMRN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMARIN Hedge Fund Activity
We have seen 4 institutional investors add shares of AMARIN stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OSAIC HOLDINGS, INC. added 114,339 shares (+1825.6%) to their portfolio in Q2 2025, for an estimated $1,854,578
- IFP ADVISORS, INC added 1,512 shares (+1890.0%) to their portfolio in Q2 2025, for an estimated $24,524
- LCM CAPITAL MANAGEMENT INC removed 149 shares (-0.3%) from their portfolio in Q3 2025, for an estimated $2,440
- INVESTORS RESEARCH CORP removed 61 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $999
- WILMINGTON SAVINGS FUND SOCIETY, FSB added 50 shares (+inf%) to their portfolio in Q3 2025, for an estimated $819
- MERCER GLOBAL ADVISORS INC /ADV removed 25 shares (-0.1%) from their portfolio in Q2 2025, for an estimated $405
- PARALLEL ADVISORS, LLC removed 10 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $162
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMARIN Analyst Ratings
Wall Street analysts have issued reports on $AMRN in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Sell" rating on 06/25/2025
To track analyst ratings and price targets for AMARIN, check out Quiver Quantitative's $AMRN forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
